Kerendia Tablet

उत्पाद अवलोकन

About Kerendia Tablet

Kerendia Tablet is a medication containing the active ingredient finerenone, classified as Nonsteroidal Mineralocorticoid-Receptor Antagonist. Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal myocardial infarctions, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

finerenone, the active ingredient in Kerendia Tablet, belongs to the Nonsteroidal Mineralocorticoid-Receptor Antagonist class. 1 INDICATIONS AND USAGE Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Kerendia Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Kerendia Tablet for extended periods without medical advice.